ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Exelon Patch 5, transdermales Pflaster - 30 Pflaster
58078001 Novartis Pharma Schweiz AG
Exelon Patch 5, transdermales Pflaster20.12.2007
Original20.12.2007
Rivastigmine (N06DA03) 
WHO-DDD 
01.99.30 Pflaster
01.99. 
B  
Yes 
IPCI
53.24Yes
    
20 %77.60
7680580780016Synthetika
3692518 
Composition
rivastigminum 9 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Beige): ad praeparationem pro 5 cm², cum liberatione 4.6 mg/24h.
Packungsbestandteile
Transdermal patch 
 
Active AgentDose
Rivastigmine9 mg
BAG: Active AgentDose
Rivastigmine9 mg
 
Inactive agentsDoseadditional_information
Acrylic Adhesive  
Butylis Methacrylatis  
Cum Liberatione4.6mg / 24h 
Dimeticone  
Drucktinte (Beige): ad Praeparationem5 cm 
Int-Rac-Alpha-Tocopherolum  
Methylis Methacrylatis Polymerisatum  
Poly(Ethylenis Terephthalas) Trägermaterial
Silicone Adhesive  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home